SCHEMBL6259138

SCHEMBL6259138

Cn1c(=O)n(Cc2ccccc2)c(=O)c2c(C(=O)OCCN3CCCC3)csc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 1/20 0.48
HPGD P15428 1/20 0.46
ALDH1A1 P00352 3/20 0.44
KMT2A Q03164 3/20 0.43
HTR4 Q13639 1/20 0.42
CYP1A2 P05177 2/20 0.41
CYP2D6 P10635 2/20 0.41
TSHR P16473 2/20 0.41
CYP2C9 P11712 1/20 0.41
THPO P40225 1/20 0.41
ADRA1A P35348 2/20 0.41
ADRA1B P35368 1/20 0.41
PMP22 Q01453 1/20 0.40
MEN1 O00255 2/20 0.40
LMNA P02545 2/20 0.40
ERCC5 P28715 1/20 0.40
FEN1 P39748 1/20 0.40
KDM4E B2RXH2 1/20 0.40
CHRM2 P08172 1/20 0.40
CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6473485 0.92 ALDH1A1 (0.48) ALDH1A1KMT2ACYP2D6TSHRADRA1A
SCHEMBL6474542 0.87 ADORA2B (0.44) HPGDALDH1A1KMT2ATSHRMEN1
SCHEMBL6473393 0.85 TSHR (0.47) ALDH1A1KMT2ATSHRMEN1LMNA
SCHEMBL6470623 0.85 ADORA2B (0.42) KMT2ATSHRMEN1LMNAERCC5
SCHEMBL6471284 0.85 MEN1 (0.46) HPGDALDH1A1KMT2ATSHRMEN1
SCHEMBL6471776 0.85 TSHR (0.45) ALDH1A1KMT2ATSHRMEN1LMNA
SCHEMBL6472082 0.85 ERCC5 (0.41) HPGDALDH1A1KMT2ATSHRMEN1
SCHEMBL6470949 0.85 POLB (0.42) HPGDALDH1A1KMT2ATSHRMEN1
SCHEMBL7023571 0.84 ERCC5 (0.41) HPGDALDH1A1KMT2ATSHRMEN1
SCHEMBL6472052 0.84 MEN1 (0.44) ALDH1A1KMT2ATSHRMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1530475-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING AN ALLOSTERIC CARBOXYLIC INHIBITOR OF MATRIX METALLOPROTEINASE-13 AND A SELECTIVE INHIBITOR OF CYCLOOXYGENASE-2 Warner-Lambert Company LLC (US) 2005-05-18 EP disclosed
EP-1530467-A2 COMBINATION OF AN ALLOSTERIC CARBOXYLIC INHIBITOR OF MATRIX METALLOPROTEINASE-13 WITH CELECOXIB OR VALDECOXIB Warner-Lambert Company LLC (US) 2005-05-18 EP disclosed
WO-2004006931-A2 PHARMACEUTICAL COMPOSTIONS COMPRISING AN ALLOSTERIC CARBOXYLIC INHIBITOR OF MATRIX METALLOPROTEINASE-13 AND A SELECTIVE INHIBITOR OF CYCLOOXYGENASE-2 WARNER-LAMBERT COMPANY LLC (US) 2004-01-22 WO disclosed
WO-2004006912-A2 COMBINATION OF AN ALLOSTERIC CARBOXYLIC INHIBITOR OF MATRIX METALLOPROTEINASE-13 WITH CELECOXIB OR VALDECOXIB WARNER-LAMBERT COMPANY LLC (US) 2004-01-22 WO disclosed
EP-1370562-A1 THIENO[2,3-D]PYRIMIDINDIONE DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS Warner-Lambert Company LLC (US) 2003-12-17 EP disclosed
WO-2002064598-A1 THIENO'2,3-D PYRIMIDINDIONE DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2002-08-22 WO disclosed